title: [Case reports of mucosal melanoma of the head and neck].
abstract: Twelve patients with mucosal melanoma in the head and neck were treated at Yokohama city University from 1975 to 1994. The sex distribution was 5 male and 7 female, and the age ranged from 40 to 79 years-old. The highest number of patients were in their sixties. In 10 cases tumors arose in the nasal cavity, in one case in the maxillary sinus and in other case in the oral cavity. The treatment modality for this tumor consisted of various combination therapies including surgery, radiotherapy, chemotherapy and immunotherapy. Combination chemotherapy consisting of dimethyltriazeno imidazole carboxamide (DTIC, Dacarbazine), amino methyl pyrimidinyl methyl chlorethyl nitrorosourea hydrochloride (ACNU) and vincristine (VCR). Cisplatin (CDDP) was recently used for cases where other chemotherapy was not effective. Surgical treatment in the initial therapy was performed in 8 patients. In three of these 8 cases, the surgical margin was positive. One of them was dead after 9 months, another dead with complication after 1 year and the other survived free of any tumor. Immunotherapy using OK-432, interleukin-2, LAK therapy and low dose CPM was effective for some patients. The 5-year survival rate was 44%. Patients with surgical treatments in the initial therapy had longer survival than those without surgical treatments.
authors.affiliation: Department of Otorhinolaryngology, Yokohama City University, School of Medicine.
authors.forename: I
authors.initials: I
authors.lastname: Mochimatsu
authors.forename: M
authors.initials: M
authors.lastname: Tsukuda
authors.forename: M
authors.initials: M
authors.lastname: Kurihara
authors.forename: H
authors.initials: H
authors.lastname: Enomoto
authors.forename: Y
authors.initials: Y
authors.lastname: Kagesato
authors.forename: S
authors.initials: S
authors.lastname: Kawai
authors.forename: Z L
authors.initials: ZL
authors.lastname: Xin
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged